Page last updated: 2024-08-24

gemcitabine and Lymphoma, T Cell, Peripheral

gemcitabine has been researched along with Lymphoma, T Cell, Peripheral in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.85)18.2507
2000's5 (19.23)29.6817
2010's17 (65.38)24.3611
2020's3 (11.54)2.80

Authors

AuthorsStudies
Cai, J; Cai, Q; Fang, Y; Huang, H; Li, Z; Liu, P; Ma, S; Su, N; Tian, X; Wang, J; Xia, Y; Zhang, Y1
Armand, P; Fisher, DC; Jacobsen, ED; Jacobson, C; Jeter, E; Kim, HT1
Choi, I; Iwasaki, H; Kada, A; Nagai, H; Saito, AM; Yamasaki, S; Yoshida, I1
Kaur, H; Lee, YS; Ong, SY; Phipps, C; Tan, L1
Kim, JS; Kim, SJ; Kim, T; Kim, WS; Koh, Y; Moon, JH; Park, GS; Park, J; Shin, HJ; Yang, DH; Yhim, HY1
Chen, BE; Crump, M; Djurfeldt, M; Good, D; Hay, AE; Kuruvilla, J; Laferriere, N; LeBrun, D; Luminari, S; Meyer, RM; Reiman, T; Savage, KJ; Sehn, LH; Shepherd, LE; Skamene, T; Soulières, D; Stakiw, J; Zhu, L1
Chang, Y; Duan, W; Fu, X; Li, L; Li, X; Li, Z; Nan, F; Sun, Z; Wang, X; Wu, J; Yan, J; Young, KH; Zhang, L; Zhang, M; Zhang, X1
Cai, H; Cao, X; Chen, M; Duan, M; Han, B; Li, J; Zhang, W; Zhang, Y; Zhou, D; Zhu, T; Zhuang, J1
Hashimoto, A; Ichikawa, H; Inui, Y; Ito, M; Kakiuchi, S; Kawamoto, S; Kurata, K; Matsuoka, H; Minami, H; Miyata, Y; Mizutani, Y; Nagao, S; Okuni, M; Saito, Y; Sakai, R; Shinzato, I; Suto, H; Tanaka, Y; Uehara, K; Yakushijin, K; Yamamoto, K1
Liu, W; Liu, X; Song, Y; Wu, M; Xie, Y; Yang, M; Zheng, W; Zhu, J1
Caplan, A; Chu, DH; Rosenbach, M; Svoboda, J1
Colvin, J; Evens, AM; Gordon, LI; Helenowski, I; Kline, J; Larsen, A; Rosen, ST; Smith, SM; van Besien, KM; Winter, JN1
Argnani, L; Chiappella, A; Corradini, P; Degl'Innocenti, D; Dodero, A; Monaco, F; Pellegrini, C; Salvi, F; Vitolo, U; Zinzani, PL1
Dong, M; Gui, L; He, X; Hu, S; Jia, B; Lin, H; Liu, P; Qin, Y; Shi, Y; Sun, Y; Wang, L; Xing, P; Yang, J; Yang, S; Zhang, C; Zhou, L; Zhou, S1
Dong, M; Gui, L; He, X; Li, Y; Liu, P; Qi, F; Shi, Y; Wang, W; Yang, J; Yang, S; Zhang, C; Zhou, S1
O'Leary, HM; Savage, KJ1
Doi, H; Imai, T; Nakajim, T; Uemura, Y; Urata, T1
Fisher, RI; LeBlanc, M; Mahadevan, D; Miller, TP; Persky, DO; Spier, CM; Unger, JM; Young, F1
Cheng, YM; Tang, Y; Wang, L; Yao, YY; Zhu, Q; Zhuang, Y; Zou, LF1
Bocchia, M; Cencini, E; Defina, M; Fabbri, A; Fontanelli, G; Gozzetti, A; Mazzei, MA; Pietrini, A; Volterrani, L1
Dong, M; Gui, L; He, XH; Liu, P; Qin, Y; Shi, YK; Yang, JL; Yang, S; Zhang, CG; Zhou, LQ; Zhou, SY1
Baek, JH; Chae, YS; Chung, IJ; Joo, YD; Kim, DH; Kim, HJ; Kim, JG; Lee, JJ; Lee, KB; Lee, WS; Sohn, CH; Sohn, SK; Yang, DH1
Arkenau, HT; Chau, I; Chong, G; Cunningham, D; Horwich, A; Matutes, E; Norman, A; Sirohi, B; Watkins, D; Wotherspoon, A1
Advani, RH; Chen, AI1
Albertini, P; Bendandi, M; Gherlinzoni, F; Magagnoli, M; Orcioni, GF; Pileri, SA; Tura, S; Zinzani, PL1
Nguyen, NP; Sallah, S; Wan, JY1

Reviews

1 review(s) available for gemcitabine and Lymphoma, T Cell, Peripheral

ArticleYear
Novel therapies in peripheral T-cell lymphomas.
    Current oncology reports, 2008, Volume: 10, Issue:5

    Topics: Alemtuzumab; Aminopterin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Deoxycytidine; Diphtheria Toxin; Enzyme Inhibitors; Gemcitabine; Humans; Immunotherapy; Interleukin-2; Lymphoma, T-Cell, Peripheral; Medical Oncology; Prognosis; Recombinant Fusion Proteins; Treatment Outcome

2008

Trials

11 trial(s) available for gemcitabine and Lymphoma, T Cell, Peripheral

ArticleYear
Phase II Trial Using Romidepsin after Gemcitabine, Dexamethasone, and Cisplatin Therapy in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma: Study Protocol.
    Acta medica Okayama, 2019, Volume: 73, Issue:5

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Depsipeptides; Dexamethasone; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral

2019
Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2021, Volume: 32, Issue:4

    Topics: Deoxycytidine; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Pyrimidines; Quinazolines; Treatment Outcome

2021
Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study
    Leukemia & lymphoma, 2017, Volume: 58, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Deoxycytidine; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Salvage Therapy; Transplantation, Autologous

2017
The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers.
    British journal of haematology, 2017, Volume: 178, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Cyclophosphamide; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Prednisone; Prospective Studies; RNA, Messenger; RNA, Neoplasm; Survival Analysis; Thalidomide; Treatment Outcome; Vincristine; Young Adult

2017
Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China.
    Annals of hematology, 2019, Volume: 98, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; China; Cisplatin; Deoxycytidine; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Survival Rate

2019
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas.
    British journal of haematology, 2013, Volume: 163, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Pyrazines; Recurrence; Treatment Outcome

2013
A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients.
    Journal of hematology & oncology, 2016, Apr-12, Volume: 9

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Depsipeptides; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Prospective Studies; Remission Induction; Survival Analysis; Thrombocytopenia; Treatment Outcome; Young Adult

2016
Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.
    Cancer, 2013, Jan-15, Volume: 119, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cisplatin; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Middle Aged; Neoplasm Staging; Treatment Outcome; Young Adult

2013
CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas.
    Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:1

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Survival Rate; Vincristine

2006
Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:12

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Mycosis Fungoides; Neutropenia; PUVA Therapy; Remission Induction; Safety; Salvage Therapy; Thrombocytopenia; Treatment Outcome

1998
Treatment of refractory T-cell malignancies using gemcitabine.
    British journal of haematology, 2001, Volume: 113, Issue:1

    Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Leukemia, Prolymphocytic; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Recurrence; Salvage Therapy; Treatment Outcome

2001

Other Studies

14 other study(ies) available for gemcitabine and Lymphoma, T Cell, Peripheral

ArticleYear
Comparison of chidamide-contained treatment modalities versus chemotherapy in the second-line treatment for relapsed or refractory peripheral T-cell lymphoma.
    Leukemia research, 2021, Volume: 111

    Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Platinum; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate

2021
Poor outcome of CHOEP induction followed by gemcitabine/busulfan/melphalan high-dose therapy and stem cell rescue for patients with newly diagnosed peripheral T-cell lymphoma.
    Bone marrow transplantation, 2022, Volume: 57, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Melphalan; Stem Cells; Transplantation Conditioning; Transplantation, Autologous

2022
Pralatrexate Induces Long-Term Remission in Relapsed Subcutaneous Panniculitis-Like T-Cell Lymphoma.
    Annals of the Academy of Medicine, Singapore, 2019, Volume: 48, Issue:9

    Topics: Adult; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Cyclophosphamide; Deoxycytidine; Dexamethasone; Doxorubicin; Folic Acid Antagonists; Gemcitabine; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell, Peripheral; Male; Neoplasm Recurrence, Local; Panniculitis; Prednisone; Remission Induction; Subcutaneous Fat, Abdominal; Vincristine

2019
Successful Bridging Chemotherapy with Gemcitabine, Carboplatin, and Dexamethasone before Unrelated Stem Cell Transplantation for Hepatosplenic T-cell Lymphoma.
    Internal medicine (Tokyo, Japan), 2019, Mar-01, Volume: 58, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Lymphoma, T-Cell, Peripheral; Middle Aged; Splenic Neoplasms

2019
A retrospective study of the CHOP, CHOPE, and CHOPE/G regimens as the first-line treatment of peripheral T-cell lymphomas.
    Cancer chemotherapy and pharmacology, 2019, Volume: 83, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Progression-Free Survival; Retrospective Studies; Thrombocytopenia; Vincristine; Young Adult

2019
Gemcitabine-induced pseudocellulitis.
    Cutis, 2018, Volume: 102, Issue:5

    Topics: Antimetabolites, Antineoplastic; Cellulitis; Deoxycytidine; Diagnosis, Differential; Female; Gemcitabine; Humans; Leg; Lymphoma, T-Cell, Peripheral; Middle Aged

2018
Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas.
    Hematology (Amsterdam, Netherlands), 2016, Volume: 21, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Deoxycytidine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Retrospective Studies; Survival Analysis; Vincristine

2016
Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma-not otherwise specified.
    Annals of hematology, 2017, Volume: 96, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult

2017
[A case of refractory pulmonary peripheral T cell lymphoma successfully treated with Cisplatin Plus Gemcitabine Plus Solumedrol].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2010, Volume: 48, Issue:1

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone Hemisuccinate; Middle Aged; Recurrence

2010
Gemcitabine, oxaliplatin and dexamethasone as salvage treatment for elderly patients with refractory and relapsed peripheral T-cell lymphoma.
    Leukemia & lymphoma, 2013, Volume: 54, Issue:6

    Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Pilot Projects; Recurrence; Salvage Therapy; Treatment Outcome

2013
Impressive activity of lenalidomide monotherapy in refractory angioimmunoblastic T-cell lymphoma: report of a case with long-term follow-up.
    Hematological oncology, 2013, Volume: 31, Issue:4

    Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cytarabine; Deoxycytidine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Drugs, Investigational; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Immunologic Factors; Lenalidomide; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Organoplatinum Compounds; Polyethylene Glycols; Prednisone; Remission Induction; Salvage Therapy; Thalidomide; Vinblastine; Vinorelbine

2013
Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma.
    Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Disease-Free Survival; Female; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Young Adult

2013
Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience.
    Haematologica, 2007, Volume: 92, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Middle Aged; Prognosis; Remission Induction; Treatment Outcome

2007
Beyond the guidelines in the treatment of peripheral T-cell lymphoma: new drug development.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2008, Volume: 6, Issue:4

    Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Arabinonucleosides; Deoxycytidine; Diphtheria Toxin; Gemcitabine; Histone Deacetylase Inhibitors; Humans; Immunosuppressive Agents; Interleukin-2; Lymphoma, T-Cell, Peripheral; Practice Guidelines as Topic; Protease Inhibitors; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Recombinant Fusion Proteins; Vascular Endothelial Growth Factor A

2008
chemdatabank.com